1. |
Heaton KW. Gall stone prevention, clues from epidemiology. In: Northfield T, Bile acids in health and disease. Kluwe: Acad Publ, 1988∶157.
|
2. |
Fourcroy D. De la substance feuilletee et cristalline contenue dans les caleuls biliaires, et de la rature des concretions uptiques cristalisees. Ann Chim, 1789; 8∶242.
|
3. |
Crawford JM, Mockel GM, Crawford AR, et al. Imaging biliary lipid secretion in the rat, ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J Lip Res, 1995; 36∶2147.
|
4. |
La Mont JT, Carey MC. Cholesterol gall stone formation Ⅱ. Pathology and pathomechanics. Prog Liver Dis, 1992; 10∶165.
|
5. |
Portincasa P, Van Erpecum KJ, VanbergeHenegouwen GP. Cholesterol crystallization in bile. Gut, 1997; 41∶138.
|
6. |
Cohen DE, Angelico M, Carey MC. Structural alterations in lecithincholesterol vesicles following interaction with monomeric and micellar bile salts. Physical chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation. J Lip Res, 1990; 31∶55.
|
7. |
Carey MC, La Mont JT. Cholesterol gall stone formation Ⅰ. Physical chemistry of bile acid biliary lipid secretion. Prog Liver Dis, 1992; 10∶139.
|
8. |
Van der Werf SOJ, Van Berge Henegouwen GP. Gallbladder contraction in patient with pigment and cholesterol stones. Gastroenterol, 1989; 97∶1497.
|
9. |
Sahlin S, Ablberg J, Reihner E, et al. Cholesterol metabolism in human gall bladder mucosa: relationship to cholesterol gall stone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment. Hepatology, 1992; 16∶320.
|